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Introduction
Cardiomyocytes are thought to terminally differentiate and 
withdraw from the cell cycle after birth. Therefore, cardiac in-
jury causes permanent myocardial loss and results in cardiac 
dysfunction (Colucci, 1997; Towbin and Bowles, 2002). How-
ever, three research groups, including ours, have recently re-
ported the isolation of cardiac stemlike cells based on the two 
distinct cell surface antigens, such as stem cell antigen 1 (Sca-1; 
Oh et al., 2003; Matsuura et al., 2004) and c-kit (Beltrami et al., 
2003). More recently, islet-1–positive cells have been reported 
to be a distinct population of cardiac progenitors in the post-
natal heart, although the most of them do not contribute to the 
formation of the left ventricle and their existence in the adult 
heart is still unclear (Cai et al., 2003; Laugwitz et al., 2005). 
When these primitive cells were cultured under appropriate 
conditions, the cells expressed cardiac proteins (Oh et al., 2003; 
Beltrami et al., 2003; Matsuura et al., 2004) and exhibited 
  spontaneous beating (Matsuura et al., 2004). When transplanted 
into injured hearts, the cells differentiated into cardiomyocytes 
(Oh et al., 2003; Beltrami et al., 2003) and cardiac function was 
improved (Beltrami et al., 2003). Although it is still unclear 
whether these primitive cells fi  t the precise defi  nition of stem 
cells, e.g., self-renewal capacity and reconstitutive capability of 
the total organ, these fi  ndings suggest that the heart has intrinsic 
stemlike cells, which may participate in its regeneration.
Side population (SP) cells are fi  rst identifi  ed as mouse 
hematopoietic stem cells with long-term multilineage recon-
stitution abilities based on their unique ability to effl  ux the 
DNA-binding dye Hoechst 33342 (Goodell et al., 1996, 1997). 
SP cells exist in a variety of organs, such as bone marrow, skel-
etal muscle, liver, brain, lung, skin, and heart (Asakura and 
Rudnicki, 2002; Montanaro et al., 2003). Zhou et al. (2001) 
reported that the ATP-binding cassette transporter, ABCG2 
(also known as breast cancer resistance protein 1 [Bcrp1]), is a 
  molecular determinant of this SP phenotype in hematopoietic 
stem cells. In mouse lung and rat liver, the SP phenotype has been 
reported to be largely determined by the expression of ABCG2 
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  S
ide population (SP) cells, which can be identiﬁ  ed by 
their ability to exclude Hoechst 33342 dye, are one of 
the candidates for somatic stem cells. Although bone 
marrow SP cells are known to be long-term repopulating 
hematopoietic stem cells, there is little information about 
the characteristics of cardiac SP cells (CSPs). When cultured 
CSPs from neonatal rat hearts were treated with oxytocin 
or trichostatin A, some CSPs expressed cardiac-speciﬁ  c 
genes and proteins and showed spontaneous beating. 
When green ﬂ  uorescent protein–positive CSPs were intra-
venously infused into adult rats, many more ( 12-fold) 
CSPs were migrated and homed in injured heart than 
in normal heart. CSPs in injured heart differentiated 
into cardiomyocytes, endothelial cells, or smooth muscle 
cells (4.4%, 6.7%, and 29% of total CSP-derived cells, 
  respectively). These results suggest that CSPs are intrinsic 
cardiac stem cells and involved in the regeneration of 
  diseased hearts.
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(Shimano et al., 2003; Summer et al., 2003). Among the tissue-
derived SP cells, bone marrow and skeletal muscle SP cells 
have been well investigated. Bone marrow SP cells were fi  rst 
identifi  ed as a primitive population of hematopoietic stem cells 
(Goodell et al., 1996). The bone marrow–derived SP cells show 
long-term multilineage reconstitution in lethally irradiated re-
cipients and form hematopoietic colonies in vitro (Goodell 
et al., 1996, 1997; Asakura and Rudnicki, 2002). Jackson et al. 
(2001) have reported that bone marrow SP cells also differ-
entiate into endothelial cells and cardiomyocytes in ischemic 
hearts. Gussoni et al. (1999) reported that transplantation of 
skeletal muscle SP cells into the irradiated mdx mouse results 
in the reconstitution of the hematopoietic compartment of 
the transplanted recipients and regeneration of donor-derived, 
dystrophin-positive muscle in the affected muscle. Skeletal muscle 
SP cells have the in vitro hematopoietic activity, and differentiate 
into skeletal myocytes when cocultured with satellite cell–
  derived myoblasts (Asakura et al., 2002). These results suggest 
that SP cells have features of somatic stem cells, and that car-
diac SP cells (CSPs) may be a promising candidate for cardiac 
stem/progenitor cells.
CSPs from postnatal hearts have been reported to differ-
entiate into cardiomyocytes when cocultured with cardiomyo-
cytes (Hierlihy et al., 2002; Martin et al., 2004; Pfi  ster et al., 
2005). However, factors that induce differentiation of CSPs into 
cardiomyocytes have not been identifi  ed. Several growth or 
  humoral factors have been reported to possess the ability to 
  induce the differentiation of primitive cells into cardiomyocytes. 
During the development, bone morphogenetic proteins (BMPs) 
and fi  broblast growth factors promote cardiogenesis in chick 
(Sugi and Lough, 1995; Schultheiss et al., 1997). Both canoni-
cal and noncanonical Wnts play an important role in the cardiac 
differentiation (Eisenberg et al., 1997; Pandur et al., 2002; Naito 
et al., 2003). Oxytocin (OT) and dynorphin B induce differ-
entiation of embryonic stem cells and P19 embryonal carcinoma 
cells into cardiomyocytes (Ventura and Maioli, 2000; Paquin 
et al., 2002; Ventura et al., 2003). Besides growth or humoral 
  factors, chemical compounds such as DMSO and 5′-azacytidine 
have been reported to promote the cardiomyocyte differen-
tiation of embryonic or somatic stem cells (Makino et al., 1999; 
Xu et al., 2002). These fi  ndings suggest that both extracellular 
signals and epigenetic modifi  cation are capable of turning the 
fate of stem cells to cardiomyocytes. Recently, Linke et al. 
(2005) have reported that c-kit–, MDR-1–, or Sca-1–positive 
cardiac stem cells migrate and proliferate in response to hepato-
cyte growth factor and insulin-like growth factor-1, respectively. 
However, it is still elusive whether CSPs, by responding to the 
ischemia-induced factors, move to the injured area of the heart 
and differentiate into cardiomyocytes.
We fi rst report that CSPs from postnatal rat hearts differ-
entiate into cardiomyocytes both in vitro and in vivo. Both OT 
and trichostatin A (TSA) induced postnatal CSPs to   differentiate 
Figure 1.  Isolation of CSPs from rat hearts at the various developmental stages and characterization of CSPs from neonatal rat hearts. (A) Flow cytometric 
analysis revealed that  4% of SP cells exist in a cell suspension after isolation from fetal rat hearts,  2% from neonatal rat hearts, and  1.2% from adult 
rat hearts. There was no SP cell fraction after the treatment with verapamil. (B) Cell surface marker antigen analysis of CSPs. In CSPs,  14% of the cells ex-
pressed CD45 (a),  59% expressed CD29 (b) and  8% expressed CD31 (c). Immunoﬂ  uorescent images revealed that the percentage of CD31+ CSPs 
(d, red) in the total cells (e, blue) is almost identical with the result of ﬂ  ow cytometry. CARDIOMYOGENESIS OF CARDIAC SIDE POPULATION CELLS • OYAMA ET AL. 331
into beating cardiomyocytes. After intravenous transplantation 
of CSPs into normal adult rats, CSPs migrated and homed in 
the interstitial space of myocardium. When CSPs were intrave-
nously transplanted into the cryoinjured heart, the number of 
CSPs was signifi  cantly larger in the border area than in the re-
mote or infarct area after transplantation. Furthermore, CSPs 
differentiated into cardiomyocytes, endothelial cells, or smooth 
muscle cells in the border area. These fi  ndings suggest that CSPs 
are resident cardiac stem cells, which can migrate and regenerate 
myocardium in response to the ischemia-induced factors.
Results
Character of SP cells from postnatal hearts
Fluorescent sorting analysis revealed that there were two popu-
lations of cells in fetal, neonatal, and adult rat hearts referred to 
the SP and the main population (MP) cells in bone marrow 
(Fig. 1 A). When the cells were incubated with 50 μM verap-
amil, which is an inhibitor of multidrug resistance (MDR) and 
MDR-like proteins, there was no SP, suggesting that rat hearts 
contain SP cells. The proportion of CSP in the total cardiac-
  derived cells was  4.0%,  2.0%, and 1.2% in fetal, neonatal, 
and adult hearts, respectively. In neonatal CSPs,  14% of the 
cells expressed CD45,  59% expressed CD29, and  8% ex-
pressed CD31 (Fig. 1 B, a–c). The percentage of CD31-positive 
cells was 13.1 ± 4.0% under the fluorescent microscope 
(Fig. 1 B, d and e). To examine whether CSPs were in a non-
cycling quiescent state, cardiac cells were stained with both 
Hoechst 33342 and Pyronin Y (PY). The percentage of cells in 
PY-negative G0 stage was signifi  cantly higher in CSPs (74.3 ± 
1.4%) than in cardiac MP cells (CMP; 34.0 ± 2.6%; Fig. 2 A, a). 
A comparable result was obtained from the bone marrow SP 
and MP cells (PY-negative G0 stage of bone marrow SP, 79.8 ± 
3.1%; bone marrow MP, 41.7 ± 5.4%; Fig. 2 A, b). This sug-
gests that CSPs represent a quiescent stem cell population in 
the heart.
We next examined whether cardiac SP cells express 
Bcrp1, the molecular determinant of the SP phenotype. RT-PCR 
analysis showed that the Bcrp1 gene was expressed in freshly 
isolated SP cells from neonatal rat hearts, as well as in those 
from mouse bone marrow, but not in MP cells of hearts and of 
bone marrow (Fig. 2 B). Immunostaining with anti-Bcrp1 anti-
body revealed that Bcrp1 protein was detected on the cell sur-
face of CSP, as well as bone marrow SP cells, but not in the MP 
cells (Fig. 2 C).
Localization of CSP in the heart
In neonatal rat hearts, most Bcrp1-positive cells ( 95.4%) were 
CD31 (Fig. 3 A, a [coronary artery] and b [capillary]), but there 
were some CD31-negative/Bcrp1-positive cells (Fig. 3 A, c, 
arrowheads). Most of the CD31-negative/Bcrp1-positive cells 
(94.3 ± 9.8%) existed in the perivascular area (Fig. 3 A, c–e, 
arrowheads). There were also a few CD31-negative/Bcrp1-
  positive cells in the interstitial space (5.6% ± 9.8%; Fig. 3 A, f–i, 
Figure 2.  Quiescence of CSPs and Bcrp1 mRNA and protein expression in CSPs. (A) Quiescence properties of CSPs. Neonatal rat heart cells and adult 
mouse bone marrow cells were subdivided into SP and MP cells, respectively, and the incorporation of PY was analyzed (a). The data shown represent the 
mean ± the SD (*, P < 0.0001; **, P < 0.0005). Hoechst and PY staining emission pattern of CMP (c), CSPs (d), bone marrow MP (e), and bone marrow 
SP (f) were shown. (B) Expression of Bcrp1 mRNA in sorted SP cells and MP cells. Adult mouse bone marrow SP and MP cells were used as positive and 
negative controls. NR, neonatal rat; AM, adult mouse; BM, bone marrow; M, molecular weight marker (100 bp ladder). (C) Bcrp1 protein expression in 
SP cells and MP cells. Confocal images revealed expression of Bcrp1 on the surface of the cardiac SP cells (a, in red), as well as bone marrow SP cells 
(c, in red) but not on cardiac (b) and bone marrow (d) MP cells. Nuclei were stained with TOPRO-3 and shown in blue. Bars, 5 μm. JCB • VOLUME 176 • NUMBER 3 • 2007  332
arrowheads) between cardiomyocytes, which were stained with 
sarcomeric α-actinin (SA; Fig. 3 A, h, arrows) and distant from 
CD31-positive vessels (Fig. 3 A, f, arrows). There were no sig-
nifi  cant differences in the percentage of CD31-negative/Bcrp1-
positive cells per total Bcrp1-positive cells among apex, mid, 
and base of left ventricles (Fig. 3 B, a), and also among cham-
bers (i.e., atrium, left, and right ventricles; Fig. 3 B, b). It has 
been reported that N-cadherin, CD29, and β1 integrin mediate 
the adhesion of stem cells to specialized mesenchymal cells and 
extracellular matrix in the niche environment (Zhang et al., 
2003; Wilson et al., 2004). Bcrp1-positive cells in the interstitial 
space coexpressed CD29 and N-cadherin around the surface of 
the cells (Fig. 4, a and b, arrowheads). At the junction of Bcrp1-
positive cells and the neighboring cell, abundant coexpression 
of CD29 and N-cadherin was observed (Fig. 4, c and d, arrow-
heads). The perivascular Bcrp1-positive cells, which were lo-
calized adjacent to the smooth muscle cell actin (SMA)–positive 
cells, coexpressed CD29 (Fig. 4, e–g, arrowheads). These fi  nd-
ings suggest that Bcrp1-positive cardiac stem or progenitor cells 
were localized in the specialized area of the myocardium, which 
may be similar to the stem cell niche in other organs, such as 
hematopoietic and gonad systems (Gonzalez-Reyes, 2003; 
Zhang et al., 2003; Wilson et al., 2004).
CSPs differentiate into cardiomyocytes 
in vitro
Isolated CSPs attached to the gelatin-coated dishes by 24 h with 
medium containing FBS. To induce differentiation into cardio-
myocytes, we cultured CSPs with various growth factors, such 
as BMP2, BMP4, and OT, or on the feeder layers of the mesen-
chymal cells. Only treatment with OT was able to induce CSP 
into beating cardiomyocytes. After 2 d of treatment with OT, 
CSPs started to show various cell shapes (Fig. 5 A, a). 10 d after 
treatment, the attached cells started to proliferate, and elongated 
spindle-shaped cells became predominant (Fig. 5 A, b). 3 wk 
after treatment, some clusters of beating cells were recognized 
among fl  attened cells (Fig. 5 A, c and Video 1, available at 
http://www.jcb.org/cgi/content/full/jcb.200603014/DC1). Next, 
we examined whether methylation inhibitors or histone deacet-
ylase inhibitors induced cardiac differentiation of CSPs. The 
treatment with TSA, but not with 5-azacytidine, induced CSPs 
into beating cardiomyocytes. The morphology of the CSPs 
treated with TSA was similar to that of CSPs treated with OT, 
although proliferation of the elongated spindle-shaped cells was 
less observed in the treatment with TSA compared with OT at 
 10 d (Fig. 5 A, d and e). 3 wk after the treatment, some clus-
ters of beating cells were recognized among fl  attened cells 
Figure 3.  Distribution of CSPs in neonatal rat hearts. (A) The expression of Bcrp1 and CD31 in the neonatal rat hearts. Bcrp1 expression was detected in 
the endothelium of arteriole and capillary, which coexpressed CD31 (a–c; red, Bcrp1; green, CD31; blue, nucleus). A CD31-negative/Bcrp1-positive cell 
was observed (c, arrowhead). Typical examples of perivascular CSPs (arrowhead in d and e; Bcrp1 in red, CD31 in green and nucleus in blue, e; a phase-
contrast image was overlaid on d) and an interstitial nonperivascular CSP (f–i, arrowhead; red, Bcrp1; blue, nucleus). Arrows indicate CD31 in f and SA 
in h. Bars, 10 μm. (B) Quantitative analysis of the distribution of CSPs. Total 713 Bcrp1-positive cells in the sections from three neonatal rat hearts were 
evaluated. (a and b) Percentage of CD31-negative/Bcrp1-positive cells/total Bcrp1-positive cells in the different portions in left ventricles (a) and the differ-
ent chambers (b). A section of left ventricle was divided into three equal lesions (base, mid, and apex), along with a long axis. The data shown represent 
the mean ± the SD.CARDIOMYOGENESIS OF CARDIAC SIDE POPULATION CELLS • OYAMA ET AL. 333
(Fig. 5 A, f, and Video 2). There were no differences between 
OT- and TSA-induced cardiomyocytes in regard to the percent-
age of beating cells (OT, 0.27 ± 0.2%; TSA, 0.50 ± 0.21%; 
Fig. 5 B, c, shaded bar) and the percentage of SA-positive cells 
(OT, 3.8 ± 3.8%; TSA, 5.5 ± 3.9%; Fig. 5 B, c, open bar). Low 
magnifi  cation immunofl  uorescent images of SA and nuclear 
DNA of OT- and TSA-induced cardiomyocytes are shown in 
Fig. 5 B (a [OT] and b [TSA]). Fine striation was observed in 
OT- and TSA-induced cardiomyocytes (Fig. S2 A, a–d). Non-
treated SP cells never exhibited spindle-shaped morphology or 
beating, and MP cells treated with OT or TSA detached from 
culture dishes within 1 wk.
Next, we examined the gene expression of cardiac tran-
scription factors and contractile proteins in CSPs by RT-PCR. 
Before treatment with OT or TSA, none of these cardiac 
genes were expressed (Fig. 5 C, P). Three weeks after treatment 
with OT or TSA, cardiac transcription factors, including 
Nkx2.5, GATA4, and myocyte-enhancer factor 2C (MEF-2C), 
and contractile proteins, such as β–myosin heavy chain and 
myosin light chain 2v (MLC-2v), were expressed (Fig. 5 C, 
OT and TSA). Treatment with 100 nM OT antagonist (OTA; 
[d(CH2)5-1,Tyr(Me)-2,Thr-4,Orn-8,Tyr-NH2-9] vasotocin) 
completely inhibited OT-induced expression of cardiac genes 
(Fig. 5 C, OT+OTA), indicating that OT induced cardiomyo-
cyte differentiation through authentic OT receptors. Cardiac 
gene expression was not observed in cells cultured with vehicle 
(Fig. 5 C, V).
To examine the expression of cardiac proteins, the CSPs 
treated with OT or TSA were stained with specifi  c antibodies 
against cardiac proteins. The cells treated with OT or TSA ex-
pressed GATA4 (Fig. 5 D, a and d), atrial natriuretic factor 
(ANF; Fig. 5 D, b, c, e, and f), cardiac troponin T (cTnT; Fig. 5 D, 
c and f), MLC2v (Fig. 5 D, a), and SA (Fig. 5 D, b, d, and e). 
Notably, staining of each contractile protein showed a fi  ne stri-
ated pattern, suggesting that treatments with OT or TSA induced 
differentiation of CSPs into mature cardiomyocytes.
Cardiac SP cells can differentiate 
into osteocytes and adipocytes
It has been reported that SP cells from skeletal muscle and bone 
marrow differentiate into various types of cells, such as adipo-
cytes, endothelial cells, and skeletal muscle and cardiac myo-
cytes (Asakura et al., 2002; Iijima et al., 2003; Tamaki et al.,
2003). To determine whether CSPs from the heart have multi-
potency of differentiation, we examined whether these cells could 
differentiate into cells other than cardiomyocytes. When CSPs 
were cultured with osteogenic inducers, including β-glycero-
phosphate, dexamethasone, and ascorbic acid-2 phosphate, 
some SP cells stained positive with alkaline phosphatase, which 
is one of the early markers of osteocytes (Fig. S1 A, a, available 
at http://www.jcb.org/cgi/content/full/jcb.200603014/DC1). 
RT-PCR analysis revealed that expression of alkaline phospha-
tase gene was induced in cardiac SP cells after treatment with 
osteogenic inducers (Fig. S1 A, b, lane O). On the other hand, 
Figure 4.  Expression of CD29 and N-cadherin in CSPs. 
Interstitial Bcrp1-positive cells coexpressed CD29 (a and c, 
  arrowhead; red, Bcrp1; green, CD29; blue, nuclei; yellow, 
coexpression of CD29 and Bcrp1). Coexpression of Bcrp1, 
CD29, and N-cadherin was shown in l b and the inlet as white, 
yellow, or light blue color, which was dependent on the degree 
of the expression of three distinct cell surface proteins. Spatial 
orientation of coexpression of CD29 and N-cadherin was 
shown in d, in which CD29 was colored in red, N-cadherin in 
green, and nuclei in blue; phase-contrast image was overlaid. 
An arrowhead in d indicates the identical Bcrp1-positive cell 
indicated in c. Perivascular Bcrp1-positive cells (arrowheads in 
e and f; red, Bcrp1; blue, SMA; and green, nuclei; phase-
  contrast image was overlaid on f) coexpressed CD29 (g, arrow-
head; red, Bcrp1; green, CD29; and blue, SMA; yellow, 
coexpression of Bcrp1 and CD29). Bars, 10 μmJCB • VOLUME 176 • NUMBER 3 • 2007  334
cardiac SP cells treated with OT or TSA did not express alkaline 
phosphatase (Fig. S1 A, b, lanes OT and T). When cardiac SP 
cells were cultured in adipogenic induction with MDI-I mixture 
for 20 d, some SP cells showed cytoplasmic accumulation of oil 
droplets stained with Oil Red O, indicating that CSPs differen-
tiated into adipocytes (Fig. S1 A, c).
CSPs migrate and home into 
the injured heart
When GFP
+ CSPs were transplanted into the normal rat via the 
tail vein, GFP
+ CSPs were distributed over the various organs, 
such as lung (Fig. 6 A, a), spleen (Fig. 6 A, b), liver (Fig. 6 A, 
c and d), skeletal muscle (Fig. 6 A, e and f), bone marrow (Fig. 
6 A, g and h), and heart (Fig. 6 A, i–l). In the lung and spleen, 
there were less GFP
+ cells at 12 wk than at 1 wk after transplan-
tation (12 wk/1 wk ratio; 0.19 for lung and 0.67 for spleen; Fig. 
6 B). On the contrary, in the liver, skeletal muscle, and heart, more 
GFP
+ cells existed at 12 wk than at 1 wk after transplantation 
(12 wk/1 wk ratio; 1.63 for liver, 2.0 for skeletal muscle, and 
3.0 for heart; Fig. 6 B). 4 wk after transplantation, some 
GFP
+ CSPs in the liver expressed albumin (Fig. 6 A, c and d). 
In skeletal muscle, GFP
+ CSPs had multiple nuclei and ex-
pressed desmin (Fig. 6 A, e and f). However, there were no 
GFP
+ CSPs positive for CD45 in the bone marrow (Fig. 6 A, 
g and h). GFP
+ CSPs in the heart expressed CD29 (Fig. 6 A, 
i and j) and were localized in the interstitial space of myocar-
dium, which was delineated by collagen type IV (Fig. 6 A, 
k and l). In the normal heart, transplanted GFP
+ CSPs did not 
  express cTnT (not depicted).
Next, we examined whether myocardial injury facilitates 
migration and homing of transplanted GFP
+ CSP- and CMP-
derived cells into the heart. 4 wk after transplantation of CMP, 
there were very few GFP
+ CMPs in both normal and injured 
hearts (Fig. 7 A, a and b). In CSP-transplanted rat hearts, there 
were a few GFP
+ CSPs, even in the normal myocardium (Fig. 
7 A, c, arrowheads), whereas many GFP
+ CSPs existed in the 
injured heart (Fig. 7 A, d, arrowheads). Many more GFP
+ CSPs 
existed in the cryoinjured heart (15.0 ± 6.2 per 10
4 cells; n = 3) 
in comparison with the normal heart (1.3 ± 1.0 per 10
4 cells; 
n = 3; Fig. 7 A) 4 wk after transplantation. There was no sub-
stantial difference in the number of GFP
+ CMPs between normal 
(0.3 ± 0.6 per 10
4 cells; n = 3) and cryoinjured heart (0.7 ± 0.6 
per 10
4 cells; n = 3; Fig. 7 A). GFP
+ CSPs were more abun-
dant in the border zone of injured hearts (12.5 ± 2.5% of total 
cells) than in the normal (4.8 ± 1.4%) or injured  (5.2 ± 1.7%) 
area (Fig. 7 B). Some GFP
+ CSPs in the border and injured 
area expressed cTnT (Fig. 8 A, a–d), vimentin (Fig. 8 A, e–h), 
von Willebrand factor (vWF; Fig. 8 A, i–l), and calponin 
Figure 5.  Differentiation of CSPs into beating cardiomyocytes. (A) Phase-contrast images of CSPs after treatment with OT (a–c) and TSA (d–f). 2 d after 
treatment with OT and TSA, CSPs slowly attached to the culture dishes (a, OT; d, TSA), proliferated rapidly after 10 d (b, OT; e, TSA), and started beating 
after 21 d (c, OT; f, TSA). Movies of beating CSP-derived cardiomyocytes are presented in Videos 1 and 2. (B) Quantitative analysis of the percentage 
of beating and SA-positive cells in CSPs treated with OT and TSA After counting the number of beating cells, the cells were immunostained with SA and 
Hoechst dye (a OT, b TSA). The percentage of beating and SA-positive cells in total nuclei was shown in c. The data shown represents the mean ± the SD 
of four to seven samples from three independent experiments. (C) Expression of cardiac protein mRNA in CSPs treated with OT or TSA. Total RNA ob-
tained from the neonatal rat heart was used as positive controls (lane H). Loading of equal amounts of RNA was conﬁ  rmed by expression of the GAPDH 
gene. P, pretreatment; V, vehicles; OTA, OT receptor antagonist; M, molecular weight marker (100-bp ladder). (D) Expression of cardiac proteins in CSPs 
after treatment with OT (a–c) or TSA (d–f). a and b, GATA4 (red); b, d, and e, SA (green); b, c, e, and f ANF (red); c and f, cTnT (green); a MLC-2v, 
(green). Nuclei were stained with TOPRO-3 (blue). Videos 1 and 2 are available at http://www.jcb.org/cgi/content/full/jcb.200603014/DC1. 
Bars: (B) 20 μm; (D) 10 μm. CARDIOMYOGENESIS OF CARDIAC SIDE POPULATION CELLS • OYAMA ET AL. 335
(Fig. 8 A, m–p). The percentage of cTnT-positive GFP
+ cells in 
the total GFP
+ cells was 4.4%, vimentin-positive GFP
+ cells 33%, 
vWF-positive GFP
+ cells 6.7%, and calponin-positive GFP
+ 
cells 29% (Fig. 8 B). The SA-actinin–positive GFP
+ cells (8.6%; 
n = 56) showed fi  ne striated sarcomere structure. The majority 
of SA-positive CSPs were small cells without organized sarco-
mere structure (Fig. S2 B, a, arrowheads), suggesting that these 
cells remain in the stage of immature cardiomyocytes or cardiac 
precursor cells. There were some well-differentiated cardio-
myocytes (Fig. S2 B, b, c, and d, arrowheads). Among the SA-
positive GFP
+ cells we examined, only a few small cells contained 
multi-nuclei without striation (Fig. S2 B, e and f, arrowheads). 
Small cell size and premature structure of this multinucleated 
cell suggest that the cell of multinuclei comes from mitosis 
rather than cell fusion. CSPs in the normal area of the injured 
heart did not express any of the aforementioned markers. These 
fi  ndings suggest that the injured myocardium recruits circulating 
CSPs, but not CMP, to the heart and stimulates the migration 
of CSPs toward the injured area. Furthermore, some environ-
mental cues from the injured heart induce the differentiation of 
CSPs into cardiomyocytes, fi  broblasts, endothelial cells, and 
smooth muscle cells.
Discussion
The novelty of our fi  ndings can be summarized as follows. First, 
we showed that a single factor, OT or TSA, can induce differen-
tiation of CSPs into beating cardiomyocytes, which is quite 
  different from the fi  ndings of previous studies (Hierlihy et al., 
2002; Martin et al., 2004; Pfi  ster et al., 2005; Tomita et al., 
2005). Previous studies used coculture method to induce differ-
entiation. Because OT is a physiological hormone, our fi  ndings 
may lead to identifi  cation of the intrinsic signals for cardio-
myocyte differentiation. Second, we showed the precise location 
Figure 6.  Tissue distribution of CSPs after intravenous 
transplantation. (A) CSPs distributed and resided in vari-
ous organs 4 wk after intravenous infusion. GFP
+ CSPs 
(green) in lung (a), spleen (b), liver (c and d), skeletal 
muscle (e and f), bone marrow (g and h), and heart (i–l). 
  Arrowhead in c and d, GFP
+ CSPs positive for albumin 
(red). Arrowheads in e and f, myotube-like GFP
+ CSPs 
positive for desmin (red). Arrowheads in g and h, GFP
+ 
CSPs negative for CD45 (red). CD29 and collagen type IV 
were represented in red in j and l. Nuclei were stained 
with TOPRO-3 (blue). Bars, 10 μm. (B) Fold increase of 
the number of GFP
+ CSPs in the organs through 1 to 12 wk. 
The relative number of GFP
+ CSP-derived cells in every 
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and distribution of CSPs in the heart. We distinguished CSPs 
from endothelial cells by immunohistochemical methods and 
clearly demonstrated the specifi  c location of CSPs. Third, we 
demonstrated the expression of CD29 and N-cadherin on the 
cell surface of CSPs, suggesting that CSPs may be regulated in 
the niche in the heart. Fourth, we fi  rst demonstrated a sequential 
event of migration and homing of CSPs in the injured heart. 
There was no report concerning the in vivo dynamics of CSPs, 
and our fi  ndings suggest that the injured heart secrets some fac-
tors that recruit CSPs. Finally, we showed that transplanted 
CSPs followed the various steps of cardiomyogenesis, such as 
cardiac precursors and immature and mature cardiomyocytes. 
In addition, we showed that CSPs differentiate into multiple 
cell lineages other than cardiomyocytes, including fi  broblasts, 
endothelial cells, and smooth muscle cells.
Two groups have reported expression of cardiac proteins in 
CSPs when cocultured with primary cardiomyocytes   (Hierlihy 
et al., 2002) or with CMP (Martin et al., 2004). Because both 
groups did not examine the contractile ability of SP-derived 
cells, it has remained unclear whether CSPs differentiate into 
mature cardiomyocytes. In addition, by the coculture method, 
it is diffi  cult to distinguish if cardiomyocyte differentiation is 
accomplished by transdifferentiation or fusion. Recently, Pfi  ster 
et al. (2005) that CD31-negative CSPs also differentiate into 
functionally beating cardiomyocytes by coculture with adult 
rat cardiomyocytes. In this study, we fi  rst demonstrated that 
Figure 7.  Homing ability of intravenously 
transplanted CSPs in cryoinjured heart. 
(A) CSPs exclusively migrate and home into in-
jured heart. Normal CMP, CMP transplanted 
into normal heart; injured CMP, CMP trans-
planted into cryoinjured heart; normal CSPs, 
CSPs transplanted into normal heart; injured 
CSPs, CSPs transplanted into cryoinjured 
heart. The data shown represents the mean ± 
the SD. *, P < 0.05. (bottom) Confocal im-
ages stained with cTnT (red), GFP (green), and 
TOPRO-3 (blue) were presented as a (normal 
CMP), b (injured CMP), c (normal CSPs), and 
d (injured CSPs). Arrowheads indicate GFP
+ 
CMPs or CSPs. Bars, 10 μm. (B) Distribution of 
CSPs in the cryoinjured heart. The number of 
GFP
+ CSPs in the normal, border, and infarct 
area was counted and represented as the per-
centage of GFP
+ CSPs per total cells in the 
  section. The data shown represent the mean ± 
the SEM. *, P < 0.05.
Figure 8.  Multilineage differentiation of CSPs. (A) CSPs in the border area of the injured heart differentiate into various types of cells. GFP
+ CSP-derived 
cells (b, f, j, n; green) expressed cTnT (a, red), vimentin (e, red), vWF (i, red), calponin (m, red). Nuclei were stained with TO-PRO-3 (blue). Merged images 
were represented in the right row. Bars, 10 μm. (B) Quantitative analysis of the frequency of expression of cell lineage marker proteins. The data were rep-
resented as the percentage of the expression of cTnT, vimentin, vWF, or calponin-positive cells per total GFP
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CSPs could differentiate into mature cardiomyocytes, which 
showed not only cardiac gene expression but also sarcomere 
formation and spontaneous beating, by single reagents such as 
OT and TSA.
There were more CSPs in the rat heart of the early develop-
mental stage. Fetal rat CSPs account for  4% of total iso-
lated cells, 2% of neonatal rat CSPs, and 1.2% of adult rat CSPs. 
Our result of the developmental change of the CSP fraction is 
similar to the previously reported one in mouse hearts (Tomita 
et al., 2005). The percentage of CSPs from adult mouse was 
 0.24% in our experiments (unpublished data). The percentage 
varied from 0.02% to 2% in previous reports (Hierlihy et al., 
2002; Oh et al., 2003; Martin et al., 2004; Tomita et al., 2005). 
Although there may be a difference in the percentage of CSPs 
among the species, the cell surface markers of isolated CSPs 
were variable among the reports. Pfi  ster et al. (2005) and Tomita 
et al. (2005) reported that a large portion of isolated CSPs from 
adult mouse are CD31 positive. In this study, CD31-positive 
cells were only 7.6% in isolated CSPs from neonatal rats. Our 
immunohistochemical analysis indicated that most Bcrp1-
positive cells in the heart are CD31-positive endothelial cells. 
The reason for these variations may be attributed to distinct iso-
lation techniques and to the fact that most endothelial cells were 
lost during the step of cell isolation discussed in this study. 
Considering the conclusion of Pfi  ster et al. (2005) that CD31-
negative CSPs represent a distinct cardiac progenitor cell popu-
lation, our CSPs isolated from neonatal rats are a condensed 
population of cardiac progenitors.
The ability to induce CSPs into the mature cardiomyo-
cytes is comparable between OT and TSA (Fig. 5 B). There 
were only a few studies showing quantitative analysis of the 
frequency of monocultured CSP-derived cardiomyocytes. Pfi  ster 
et al. (2005) reported that  10% of CD31
−/Sca-1
+/CSP ex-
pressed disorganized α-actinin and troponin I, but they did not 
show the characteristic sarcomeric organization and spontaneous 
beating, suggesting immature cardiomyocytes. Tomita et al. 
(2005) have reported that when CSP-derived cardiosphere was 
dissociated and cultured, 0.28% of the total cells differentiated 
into cardiomyocytes, which were positive for α-actinin and sar-
comeric myosin (Tomita et al., 2005). In this study,  5% of 
CSPs differentiated into cardiomyocytes with fi  ne sarcomere 
structures and spontaneous beating (Fig. S2 A, a–f). Therefore, 
both OT and TSA possess more powerful cardiogenic activity 
against CSPs than the previously reported methods.
OT, a hypothalamic neuropeptide, induces uterine con-
traction and milk ejection. In recent years, however, functional 
OT receptors have been found in various organs, such as kidney, 
ovary, testis, thymus, heart, vascular endothelium, osteoclasts, 
myoblasts, pancreatic islet cells, adipocytes, and several types 
of cancer cells (Gimpl and Fahrenholz, 2001). OT receptors and 
OT biosynthesis are detected in atria and ventricles of the rat 
heart, and OT is thought to be involved in ANF release from 
cardiomyocytes (Gutkowska et al., 1997; Jankowski et al., 
1998). CSPs are a heterogenous population of the cells, includ-
ing cardiac stem/progenitor cells, endothelial progenitor cells, 
and other unknown cells. When CSPs are treated with OT or 
TSA, mesenchymal-like cells were observed near cardiomyocytes. 
Presently, we do not have the evidence to indicate that OT re-
ceptors are expressed in cardiac stem/progenitor cells, but not in 
other cells. It has recently been reported that elevated OT and 
OT receptor protein levels in growing fetal hearts and OT re-
ceptor immunostaining were predominantly detected in car-
diomyocytes and endothelial cells (Jankowski et al., 2004). These 
observations suggest that OT acts on cardiomyogenesis, but it 
remains to be determined whether OT has direct effects on car-
diac stem cells.
We have recently reported that OT induces differentia-
tion of adult cardiac Sca-1 cells into mature cardiomyocytes 
(Matsuura et al., 2004). Because of the lack of Sca-1 in rats and 
the unavailability of decent antibodies against rat c-kit, we 
could not determine the relationship between CSPs and other 
cardiac stem cells populations, such as Sca-1
+ or c-kit
+ cells. 
The expression of cardiac transcription factors was absent in 
freshly isolated CSPs. We performed semiquantitative RT-PCR, 
showing the expression levels of Nkx-2.5 in CSPs were negligible 
(Fig. S1C, a and b). Therefore, CSPs may be more primitive 
stem or progenitor cells in comparison with cardiac Sca-1
+ 
cells, in which faint but substantial expressions of cardiac tran-
scription factors were observed. Our fi  ndings suggest that the 
OT-mediated signaling may play a pivotal role in the differenti-
ation of various cardiac stem cells into cardiomyocytes.
Histone deacetylases (HDAC) catalyze the deacetylation 
from conserved lysine residues in the N-terminal tails of his-
tones (Hassig and Schreiber, 1997). Silencing of genes has 
been shown to be accomplished by histone deacetylation, and 
inhibition of HDAC reverses the silencing effect. HDAC are 
critically involved in cell cycle regulation, cell proliferation, 
cancer development, and cell differentiation (Marks et al., 
2003; Legube and Trouche, 2003). Recently, HDAC inhibitors 
such as TSA, valproic acid, and butyric acid have been reported 
to modulate cell type–specifi  c gene expression. The lymphoid 
lineage-determining factor Ikaros is repressed under the cir-
cumstances with hypoacetylation of core histones at promoter 
sites, and this repression is relieved by TSA (Koipally et al., 
1999). Hsieh et al. (2004) reported that valproic acid induces 
neural differentiation of adult hippocampal neural progenitors 
through the induction of neuroD. In this study, TSA induced de 
novo expressions of Nkx2.5, GATA4, and MEF2C, suggesting 
that acetylation of chromatin activates specifi  c master genes, 
products of which promote the expression of a series of cardiac 
transcription factors. It remains to be determined what genes 
are activated and involved in cardiomyocyte differentiation by 
the treatment of TSA.
SP cells are thought to be a population of quiescent stem 
cells, which reside in the niche of the organs and contribute 
to life-long maintenance or repair of the tissue (Asakura and 
Rudnicki, 2002; Montanaro et al., 2003). Quiescence of CSPs was 
confi  rmed by PY staining. Stem cell niches play a pivotal role 
in controlling the self-renewal and differentiation of stem cells 
(for review see Moore and Lemischka, 2006). Niches consist of 
stem cells, niche stromal cells, and extracellular matrix, and the 
interaction between stem cells and the cellular microenviron-
ments through adhesion molecules is important, as are paracrine 
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N-cadherin on their cell surface and were located in the intersti-
tial space and perivascular area. Although the niche stroma cells 
for cardiac Bcrp1-positive cells were not specifi  ed in this study, 
the fact that most Bcrp1-positive cells existed in the perivascular 
area suggests that pericytes or adventitial mesenchymal cells 
may be a component of the stem cell niches. During the prepa-
ration of this manuscript, Urbanek et al. (2006) reported that 
c-kit–positive cardiac stem cells and lineage-committed cells 
are clustered together, forming their niches in adult mouse heart. 
In their paper, α4β1 integrin–mediated adhesion to laminin and 
fi  bronectin, as well as E- and N-cadherin–mediated cell–cell 
communications are supposed to be the fundamental structure 
of the cardiac stem cell niches. Some groups have reported that 
the frequency of cardiac stem cell clusters, including MDR1-
positive cells, is inversely related to the hemodynamic load sus-
tained by the anatomical regions of the heart; they accumulate 
in the atria and apex and are less numerous at the base and mid 
portion of the left ventricle (Leri et al., 2005). However, the 
  frequency of CD31-negative/Bcrp1-positive cells in neonatal 
hearts did not show signifi  cant difference in the anatomical re-
gions in this study. The reason for this discordant result may be 
that the left ventricle of neonatal hearts is under less hemo-
dynamic load than that of adult hearts.
Intravenously transplanted CSPs were trapped in the lung 
and spleen, but redistributed in heart, liver, and skeletal muscle. 
CSPs in the heart were localized in the basal membrane between 
the myocardium and expressed CD29 on their cell surface, sug-
gesting that CSPs penetrate the fenestrated endothelium, migrate 
into the basal lamina, and reside along with cardiomyocytes. 
Although some CSPs in liver and skeletal muscle expressed 
 tissue-specifi  c proteins such as albumin and desmin, respec-
tively, transplanted CSPs in the normal heart did not express 
cardiac contractile proteins. It has been reported that trans-
planted bone marrow cells fuse with hepatocytes and skeletal 
muscle and regenerate the tissues (Camargo et al., 2003; 
Corbel et al., 2003; Vassilopoulos et al., 2003; Wang et al., 
2003). Therefore, highly fusogenic hepatocytes and myotubes 
may fuse with transplanted CSPs and express differentiated 
marker proteins, whereas CSPs homing to the heart may not fuse 
with cardiomyocytes, and thus maintain stem or progenitor status.
Tissue damage, such as total body irradiation or chemo-
therapy, leads to secretion of chemokines and cytokines and 
  facilitates hematopoietic stem cell migration and repopulation 
(Lapidot et al., 2005). Torrente et al. (2003) reported that  skeletal 
muscle–derived stem cells home and migrate to the perivascular 
space of a damaged muscle of mdx mice after intravenous trans-
plantation, and that the molecules involved in this process are 
L-selectin and mucosal addressin cell adhesion molecule-1. 
CSPs distributed in lung, spleen, liver, and skeletal muscle, but 
did not home specifi  cally to the normal heart tissue. However, 
CSPs infused into rats with cryoinjured hearts homed in the 
heart, suggesting that the factors inducing migration and homing 
of stem cells may be released from injured heart. Further studies 
are necessary to understand the molecular mechanisms of differ-
entiation, expansion, and migration of cardiac stem cells.
Materials and methods
Cell preparation and reagents
Neonatal Wistar rats and wild-type mice (C57BL/6) were purchased from 
Takasugi Experimental Animal Supply Co. LTD. Neonatal and adult GFP 
transgenic rats were purchased from Japan SLC, Inc. (Ito et al., 2001). All 
protocols were approved by the Institutional Animal Care and Use Committee 
of Chiba University. Cardiomyocytes of neonatal rats were prepared as 
previously described (Komuro et al., 1990). Rabbit anti–mouse Bcrp1 anti-
body was provided by S. Takeda (National Center of Neurology and Psy-
chiatry, Tokyo, Japan; Uezumi et al., 2006). Other antibodies used in these 
studies are listed in Table I. Other reagents that are not speciﬁ  ed were ob-
tained from Sigma-Aldrich.
Isolation of CSPs and Pyronin Y staining
Cardiac cells were resuspended at the density of 1.0 × 10
6 cells/ml in PBS 
with 3% FBS. The cells were incubated in 1 μg/ml Hoechst 33342 dye for 
60 min at 37°C in the dark, with or without 50 μM verapamil. After the 
Table I. Primary antibodies used
Antibodies Clone Conjugate Used Source
anti-CD31 TLD-3A12 PE BD Biosciences
anti-CD45 OX-1 PE BD Biosciences
anti-CD29 HMβ1-1 Unconjugated BD Biosciences
FITC
anti-cTnT RV-C2 Unconjugated German Resource Centre for Biological Material
anti-ANF polyclonal Unconjugated Peninsula Laboratories
anti-GATA4 polyclonal Unconjugated Santa Cruz Biotechnology, Inc.
anti–MLC-2v F109.3E1 Unconjugated BioCytex
anti–β-galactosidase polyclonal Unconjugated CHEMICON International, Inc.
anti-vimentin monoclonal Unconjugated PROGEN
anti-vWF polyclonal Unconjugated DAKO Cytomation
anti-SMA 1A4 Unconjugated DAKO Cytomation
anti-calponin CALP Unconjugated DAKO Cytomation
anti-desmin polyclonal Unconjugated DAKO Cytomation
anti–N-cadherin 3B9 Unconjugated Zymed Laboratories
anti-SA EA-53 Unconjugated Sigma-Aldrich
anti-GFP monoclonal Unconjugated Marine Biological Laboratory
anti-GFP polyclonal Unconjugated Marine Biological Laboratory
anti-albumin polyclonal Unconjugated Intercell TechnologiesCARDIOMYOGENESIS OF CARDIAC SIDE POPULATION CELLS • OYAMA ET AL. 339
  incubation, cells were analyzed for Hoechst 33342 dye efﬂ  ux by EPICS 
ALTRA ﬂ  ow cytometric analysis (Beckman Coulter). Before analysis, 2 μg/ml 
of propidium iodide was added to distinguish live cells from dead cells. 
Hoechst 33342 dye was excited at 350 nm using UV laser. Fluorescent 
emission was detected through 450-nm BP (Hoechst blue) and 675-nm LP 
(Hoechst red) ﬁ  lters, respectively. Propidium iodide in cells was excited at 
488 nm, and ﬂ  uorescence emission was detected through a 610-nm BP 
  ﬁ  lter. For cell surface marker analysis, the cells were incubated with phyco-
erythrin (PE)-conjugated anti-CD45 antibody, PE-conjugated anti-CD31 
antibody, or FITC-conjugated anti-CD29 antibody for 10 min on ice and 
washed with PBS supplemented with 3% FBS. The procedures for mouse 
bone marrow SP cells and PY staining were previously described (Goodell 
et al., 1996; Arai et al., 2004).
Cell culture
CSPs were cultured on gelatin-coated dishes with Iscove’s Modiﬁ  ed Dulbecco’s 
Medium supplemented with 10% FBS. 24 h after seeding, the cells were 
treated with 10 pg/ml TSA or 100 nM of OT (both Sigma-Aldrich) for 72 h.
CSP transplantation of cryoinjured heart model
Male Wistar rats were anesthetized with 50 mg/kg ketamine i.p. and xyli-
dine (10 mg/kg, i.p.) and a 6-mm aluminum rod, which was cooled to 
–190°C by immersion in liquid nitrogen, applied to the left ventricular free 
wall to produce cryoinjury, after the tail vein injection of 3 × 10
5 CSPs or 
CMPs derived from neonatal GFP transgenic into syngenic wild-type adult 
rats (CSP transplantation, n = 3; CMP transplantation, n = 3). As control 
groups, normal rats, which were subjected to the injection of 3 × 10
5 of 
CSPs (n = 3) or CMP (n = 3) were prepared. 4 wk after injection, rats 
were killed and lung, spleen, liver, skeletal muscle, and heart were ﬁ  xed 
according to the periodate-lysine-paraformaldehyde ﬁ  xative methods and 
snap-frozen in liquid nitrogen.
Immunocytochemistry and histochemistry
Cells were ﬁ   xed with 4% paraformaldehyde and preblocked with PBS 
containing 2% donkey serum, 2% BSA, and 0.2% NP-40 for 30 min. 
  Primary antibodies in PBS containing 2% donkey serum, 2% BSA, and 
0.1% NP-40 were applied overnight at 4°C. FITC-, Cy3-, or Cy5-conjugated 
secondary antibodies were applied to visualize expression of speciﬁ  c 
  proteins. Nuclear staining was performed with TOPRO-3 (Invitrogen). To 
detect expression of Bcrp1, fresh isolated cells were ﬁ  xed in methanol/
ethanol (1:1) for 1 min, and the cells were incubated with rabbit anti–
mouse Bcrp1 antibodies for 2 h at room temperature. After washing three 
times with PBS containing 2% donkey serum, the secondary antibody was 
added for 1 h.
6-μm cryostat sections of fresh-frozen or ﬁ   xed rat heart were 
prepared. Fresh-frozen sections were ﬁ  xed with 1% formaldehyde for 15 min 
at room temperature. Blocking and staining procedures were performed 
according to the protocol described in the previous paragraph. Confocal 
images were acquired at room temperature using a microscope (Radiance 
2000; Bio-Rad Laboratories) with Plan Apo 60×/1.40 NA oil immer-
sion objective (Nikon) and Laser Sharp 2000 confocal software (Bio-Rad 
Laboratories). For Fig. 1 B (d and e), Fig. 5 B (a and b), Fig. S1 A (a and c), 
and Fig. S3 A (a–f), Axioscop 2 Plus (Carl Zeiss MicroImaging, Inc.) with 
Plan-NEOFLUAR 100×/1.30 NA oil immersion and 40×/0.75 NA 
  objectives (Carl Zeiss MicroImaging, Inc.).
RNA extraction and RT-PCR analysis
SP cells were isolated from cardiac cells using EPICS ALTRA ﬂ  ow cytometric 
sorting. Total RNA was obtained from SP cells, TSA-treated SP cells, and 
the neonatal rat heart by RNA-Bee reagent (TEL-TEST). RT-PCR was per-
formed using 0.1 mg of total RNA. For semiquantitative analysis, reverse 
transcribed products were pooled and ﬁ  vefold serial dilutions were used 
for PCR. PCR was performed in a reaction volume of 20 μl with 200 nM 
deoxynucleoside triphosphates, 500 nM each of sense and antisense prim-
ers, and 2.5 U/100 μl Taq polymerase (Roche). Every PCR condition was 
conﬁ  rmed to be within the linear range and within semiquantitative range 
for these speciﬁ  c genes and primer pairs. The primers used in this study 
and the PCR conditions are described in Table II. To conﬁ  rm that the ob-
tained bands were not derived from contaminated genomic DNA, a nega-
tive experiment was done for each sample without reverse transcriptase 
Table II. PCR primers and PCR conditions
Primer Product Size Annealing Temperature
bp °C
β myosin heavy chain
 5 ′-G  C  C  A  A  C  A  C  C  A  A  C  C  T  G  T  C  C  A  A  G  T  T  C  -3′ 205 66
 5 ′-T  G  C  A  A  A  G  G  C  T  C  C  A  G  G  T  C  T  G  A  G  G  G  C  -3′
MLC-2v
 5 ′-G  C  C  A  A  G  A  A  G  C  G  G  A  T  A  G  A  A  G  G  -3′ 499 55
 5 ′-C  T  G  T  G  G  T  T  C  A  G  G  G  C  T  C  A  G  T  C  -3′
Nkx-2.5
 5 ′-C  A  G  T  G  G  A  G  C  T  G  G  A  C  A  A  A  G  C  C  -3′ 216 55
 5 ′-T  A  G  C  G  A  C  G  G  T  T  C  T  G  G  A  A  T  T  T  -3′
GATA4
 5 ′-C  T  G  T  C  A  T  C  T  C  A  C  T  A  T  G  G  G  C  A  -3′ 275 60
 5 ′-C  C  A  A  G  T  C  C  G  A  G  C  A  G  G  A  A  T  T  T  -3′
MEF2C
 5 ′-G  G  C  C  A  T  G  G  T  A  C  A  C  C  G  A  G  T  A  C  A  A  C  G  A  G  C  -3′ 401 62
 5 ′-G  G  G  G  A  T  C  C  C  T  G  T  G  T  T  A  C  C  T  G  C  A  C  T  T  G  G  -3′
ALP
 5 ′-T  T  G  A  A  A  C  T  C  C  A  A  A  A  G  C  T  C  A  A  C  A  C  C  A  -3′ 450 62
 5 ′-T  C  T  C  G  T  T  A  T  C  C  G  A  G  T  A  C  C  A  G  T  C  C  C  -3′
Bcrp1
 5 ′-C  C  A  T  A  G  C  C  A  C  A  G  G  C  C  A  A  A  G  T  -3′ 327 56
 5 ′-G  G  G  C  C  A  C  A  T  G  A  T  T  C  T  T  C  C  A  C  -3′
GAPDH
 5 ′-T  T  C  T  A  C  C  C  A  C  G  G  C  A  A  G  T  T  C  A  A  -3′ 470 63
 5 ′-G  G  A  T  G  A  C  C  T  T  G  C  C  C  A  C  A  G  C  -3′
β-actin
 5 ′-G  G  A  C  C  T  G  G  C  T  G  G  C  C  G  G  G  A  C  C  -3′ 583 60
 5 ′-G  C  G  G  T  G  C  A  C  G  A  T  G  G  A  G  G  G  G  C  -3′JCB • VOLUME 176 • NUMBER 3 • 2007  340
before PCR. Ampliﬁ  ed samples were electrophoresed on 2% agarose gels 
and stained with ethidium bromide. For semiquantitative RT-PCR analysis, 
PCR was performed on undiluted cDNA and on ﬁ  vefold serial dilutions of 
cDNA, and the intensity of the ethidium bromide–stained bands was quanti-
ﬁ   ed using the Image program (Wayne Rasband, National Institutes of 
Health). Diluted pools showing the same intensity for β-actin were used for 
further PCR and quantiﬁ  cation of Nkx-2.5 gene expression.
Differentiation cultures for osteocytes and adipocytes
The protocol for osteocyte- and adipocyte-induction was previously de-
scribed (Matsuura et al., 2004). Alkaline phosphatase staining (leukocyte 
alkaline phosphatase assay kit) was used to examine the differentiation of 
osteocytes. For detection of accumulated oil droplets, Oil Red O staining 
was performed followed by nuclear hematoxylin counterstaining.
Statistical analysis
The signiﬁ  cance of differences among mean values was determined by 
t test. P values were corrected for multiple comparisons by the Bonferoni 
correction. The accepted level of signiﬁ  cance was P < 0.05.
Online supplemental material
Fig. S1 shows the osteogenic and adipogenic differentiation of CSPs. Fig. 
S2 shows the ﬁ  ne sarcomeric patterns of OT- and TSA-induced CSP-derived 
cardiomyocytes. Live images of beating cells were taken with an inverted 
microscope (Carl Zeiss MicroImaging, Inc.) equipped with chilled charge-
coupled device camera (Hamamatsu) using I-O DATA Videorecorder 
software. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200603014/DC1.
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